Company: JACS-RI
Filing Date: 2025-01-15
Form Type: 10-Q
Source: 0001213900-25-003881
Chunk: 2

Company: Jackson Acquisition Co II
Filing Date: 2025-01-15
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
 2024 (Unaudited)

    —

    $
    —

    5,750,000

    $
    575

    $
    24,425

    $
    (49,568
    )
     
    $
    (24,568
    )

  (1) Includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriter’s over-allotment option is exercised (see Note 5). On December 11, 2024, the Company consummated its IPO and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 750,000 shares of Class B ordinary shares were no longer subject to forfeiture. 

The accompanying notes are an integral part of
the unaudited condensed financial statements.

3

JACKSON ACQUISITION COMPANY II

CONDENSED STATEMENT OF CASH FLOWS

FOR THE PERIOD FROM SEPTEMBER 11, 2024 (INCEPTION)
THROUGH SEPTEMBER 30, 2024

(UNAUDITED)

    Cash Flows from Operating Activities: 

    Net loss 
    $(49,568)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Formation costs (included in general and administrative costs) paid
    via issuance of founder shares 
     8,148 
  
    Payment of general and administrative costs  via promissory
    note 
     36,420 
  
    Changes in operating assets and liabilities: 

    Accrued expenses 
     5,000 
  
    Net cash used in operating activities 
     — 

    Net Change in Cash 
     — 
  
    Cash – Beginning of period 
     — 
  
    Cash – End of period 
    $— 

    Non-Cash investing and financing activities: 

    Deferred offering costs included in accrued offering costs 
    $93,000 
  
    Deferred offering costs paid through promissory note - related party 
    $83,948 
  
    Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 
    $2,753 
  
    Deferred offering costs contributed by sponsor through promissory note 
    $10,850